Nivolumab

4 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Nivolumab
Treatment and conditionWhere it standsTrials
Nivolumab for carcinoma, transitional cellPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Nivolumab for neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Nivolumab for sarcomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Nivolumab for squamous cell carcinoma of head and neckPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1